Dedicated to Representing Clients Injured by Unsafe & Defective Products Nationwide

We have focused our practice on mass tort litigation since 2000, putting client's
concerns first each and every day along the way.

Invokana Claims Attorney

Over 8,500 Clients Successfully Represented Nationwide

Invokana was a drug developed to help people with Type II diabetes maintain healthy blood sugar levels. Unlike most diabetes medications, Invokana doesn’t stimulate the production of more insulin—instead, it prevents excess blood sugar from being reabsorbed into the blood. To eliminate the sugar, it pushes blood sugar through the kidneys into the urine.

Though initially hailed as a revolutionary new way of treating diabetes, in reality, Invokana has been linked to dangerous side effects, some of which are fatal and hard to notice until it’s too late. The kidneys are not meant to handle the high volume of sugar the drug demands. As a result, the kidneys go into shutdown mode, which puts the rest of the body at risk.

The side effects linked to Invokana include:

  • Kidney failure
  • Toxic shock
  • Heart failure
  • Ketoacidosis
  • Diabetic coma
  • Leg and foot amputation

Each of these conditions are life-altering at best—left alone or caught too late, and patients could face lethal consequences thanks to any of these side effects. The odds of requiring a leg or foot amputation alone could double from taking Invokana, according to the FDA following the results of two clinical trials.

How Invokana Puts Patients At Risk

Invokana belongs to a class of drugs known as SGLT2 inhibitors. These drugs work by preventing the kidneys from allowing sugar to be reabsorbed into the bloodstream. Instead, it dumps incredibly harmful amounts of sugar through the body’s filtration system. These have a few potential effects: one is that the kidneys completely fail, which puts your body at risk for toxic shock.

Toxic shock causes widespread organ failure as the pollutants in your bloodstream build up. This alone is potentially fatal, but that’s not the only possible risk.

When your bloodstream has insufficient glucose, your body turns to its fat stores to keep your body fueled; that’s why Invokana has become known for weight loss. The breakdown of fat in the blood creates a byproduct called a “ketone.” In small amounts, ketones are harmless—but when ketone levels climb too high, it can dehydrate the brain and kidney. Ketoacidosis can be the primary cause of a diabetic coma or kidney failure, which again puts the body at risk for toxic shock.

How to Know If You Have a Case

Verhine & Verhine PLLC has gotten results for over 8,000 people in complex pharmaceutical cases nationwide. We have stood up to the largest manufacturers and corporations in the world, fighting for our clients to get medical care, lost wages, and future treatment. Our vast experience makes us one of the leading choices for clients facing years of drug injury litigation.

Our team’s understanding of these cases, our investigative experience, and our ability to identify the markers of a valid claim means we can get you answers. We can help patients understand what happened to them and why—and most importantly, we can help provide for their future.

Invokana is manufactured by one of the giants of the pharmaceutical injury—Janssen Pharmaceuticals, a child company of Johnson & Johnson. Their defense cases are well-funded and well-prepared. Our firm is ready to level the playing field on your behalf—you just need to call (888) 905-1403 for a free consultation. Our team will lay out your options and fight to get you results like we have for thousands of others.

Contact Verhine & Verhine PLLC today—we look forward to giving you a voice.

Testimonials from Our Clients

  • “I Was Very Happy With the Result of My Case ”

    Yvette S.

  • “ They Took the Extra Time to Contact Me ”

    Bill C.

  • “ All My Questions Were Answered to My Satisfaction ”

    Peter A.

  • “Mr. Verhine Made Me Feel Very Comfortable”

    Brandi M.

  • “My Questions Were Always Answered”

    Deanna F.